Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Amesite Inc. stock logo
AMST
Amesite
$1.12
-3.4%
$1.07
$0.77
$4.78
$7.60M0.9896,493 shs582,796 shs
Entero Therapeutics, Inc. stock logo
ENTO
Entero Therapeutics
$3.65
+2.3%
$3.84
$0.32
$5.84
$5.80M1.192.80 million shs151,950 shs
LM Funding America, Inc. stock logo
PWCM
LM Funding America
$1.17
-11.4%
$3.14
$1.12
$35.75
$1.23M2.431.21 million shs711,946 shs
Versus Systems Inc. stock logo
VS
Versus Systems
$1.33
+1.9%
$1.36
$0.75
$2.47
$8.08M1.359,697 shs8,760 shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Amesite Inc. stock logo
AMST
Amesite
+8.41%+20.82%+17.18%-26.58%-56.88%
Entero Therapeutics, Inc. stock logo
ENTO
Entero Therapeutics
0.00%-14.41%+17.40%-26.26%+74.95%
LM Funding America, Inc. stock logo
PWCM
LM Funding America
0.00%0.00%0.00%-53.66%-91.92%
Versus Systems Inc. stock logo
VS
Versus Systems
+0.77%-1.53%-7.19%+20.56%-32.11%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Amesite Inc. stock logo
AMST
Amesite
$1.12
-3.4%
$1.07
$0.77
$4.78
$7.60M0.9896,493 shs582,796 shs
Entero Therapeutics, Inc. stock logo
ENTO
Entero Therapeutics
$3.65
+2.3%
$3.84
$0.32
$5.84
$5.80M1.192.80 million shs151,950 shs
LM Funding America, Inc. stock logo
PWCM
LM Funding America
$1.17
-11.4%
$3.14
$1.12
$35.75
$1.23M2.431.21 million shs711,946 shs
Versus Systems Inc. stock logo
VS
Versus Systems
$1.33
+1.9%
$1.36
$0.75
$2.47
$8.08M1.359,697 shs8,760 shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Amesite Inc. stock logo
AMST
Amesite
+8.41%+20.82%+17.18%-26.58%-56.88%
Entero Therapeutics, Inc. stock logo
ENTO
Entero Therapeutics
0.00%-14.41%+17.40%-26.26%+74.95%
LM Funding America, Inc. stock logo
PWCM
LM Funding America
0.00%0.00%0.00%-53.66%-91.92%
Versus Systems Inc. stock logo
VS
Versus Systems
+0.77%-1.53%-7.19%+20.56%-32.11%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Amesite Inc. stock logo
AMST
Amesite
1.00
SellN/AN/A
Entero Therapeutics, Inc. stock logo
ENTO
Entero Therapeutics
1.00
SellN/AN/A
LM Funding America, Inc. stock logo
PWCM
LM Funding America
1.00
SellN/AN/A
Versus Systems Inc. stock logo
VS
Versus Systems
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest PWCM, VS, ENTO, and AMST Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/21/2026
Amesite Inc. stock logo
AMST
Amesite
Reiterated RatingSell (E+)
8/21/2026
Versus Systems Inc. stock logo
VS
Versus Systems
DowngradeSell (D-)Sell (E+)
8/5/2026
Versus Systems Inc. stock logo
VS
Versus Systems
UpgradeSell (E+)Sell (D-)
7/21/2026
Versus Systems Inc. stock logo
VS
Versus Systems
DowngradeSell (D-)Sell (E+)
7/6/2026
Versus Systems Inc. stock logo
VS
Versus Systems
UpgradeSell (E+)Sell (D-)
6/24/2026
LM Funding America, Inc. stock logo
PWCM
LM Funding America
Reiterated RatingSell (E+)
6/17/2026
Versus Systems Inc. stock logo
VS
Versus Systems
DowngradeSell (D-)Sell (E+)
6/3/2026
Versus Systems Inc. stock logo
VS
Versus Systems
UpgradeSell (E+)Sell (D-)
5/26/2026
Amesite Inc. stock logo
AMST
Amesite
DowngradeSell (D-)Sell (E+)
(Data available from 8/25/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Amesite Inc. stock logo
AMST
Amesite
$110K66.69N/AN/A$0.60 per share1.87
Entero Therapeutics, Inc. stock logo
ENTO
Entero Therapeutics
N/AN/AN/AN/A($2.45) per shareN/A
LM Funding America, Inc. stock logo
PWCM
LM Funding America
$8.77M0.12N/AN/A$59.13 per share0.02
Versus Systems Inc. stock logo
VS
Versus Systems
$2.18M3.77N/AN/A$0.39 per share3.40
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Amesite Inc. stock logo
AMST
Amesite
-$3.62M-$0.63N/AN/AN/A-873.02%-154.31%-129.67%9/2/2026 (Estimated)
Entero Therapeutics, Inc. stock logo
ENTO
Entero Therapeutics
-$18.06M-$1.69N/AN/AN/AN/A-461.02%-14.72%N/A
LM Funding America, Inc. stock logo
PWCM
LM Funding America
-$26.92M-$60.51N/AN/AN/A-368.68%-102.63%-67.53%N/A
Versus Systems Inc. stock logo
VS
Versus Systems
-$1.79M-$0.35N/AN/AN/AN/A-70.36%-61.70%N/A

Latest PWCM, VS, ENTO, and AMST Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
9/2/2026Q4 2026
Amesite Inc. stock logo
AMST
Amesite
-$0.96N/AN/AN/A$0.25 millionN/A
8/14/2026Q2 2026
Versus Systems Inc. stock logo
VS
Versus Systems
-$29.0721$0.10+$29.1721$0.10$1.14 million$0.01 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Amesite Inc. stock logo
AMST
Amesite
N/AN/AN/AN/AN/A
Entero Therapeutics, Inc. stock logo
ENTO
Entero Therapeutics
N/AN/AN/AN/AN/A
LM Funding America, Inc. stock logo
PWCM
LM Funding America
N/AN/AN/AN/AN/A
Versus Systems Inc. stock logo
VS
Versus Systems
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Amesite Inc. stock logo
AMST
Amesite
N/A
4.33
4.33
Entero Therapeutics, Inc. stock logo
ENTO
Entero Therapeutics
N/A
2.62
2.62
LM Funding America, Inc. stock logo
PWCM
LM Funding America
0.10
1.13
1.13
Versus Systems Inc. stock logo
VS
Versus Systems
N/A
4.01
4.01

Institutional Ownership

CompanyInstitutional Ownership
Amesite Inc. stock logo
AMST
Amesite
3.60%
Entero Therapeutics, Inc. stock logo
ENTO
Entero Therapeutics
12.30%
LM Funding America, Inc. stock logo
PWCM
LM Funding America
22.73%
Versus Systems Inc. stock logo
VS
Versus Systems
60.72%

Insider Ownership

CompanyInsider Ownership
Amesite Inc. stock logo
AMST
Amesite
36.50%
Entero Therapeutics, Inc. stock logo
ENTO
Entero Therapeutics
0.75%
LM Funding America, Inc. stock logo
PWCM
LM Funding America
15.03%
Versus Systems Inc. stock logo
VS
Versus Systems
0.24%
CompanyEmployeesShares OutstandingFree FloatOptionable
Amesite Inc. stock logo
AMST
Amesite
206.55 million4.16 millionNot Optionable
Entero Therapeutics, Inc. stock logo
ENTO
Entero Therapeutics
91.59 million3.34 millionN/A
LM Funding America, Inc. stock logo
PWCM
LM Funding America
8934,000590,000No Data
Versus Systems Inc. stock logo
VS
Versus Systems
86.21 million6.20 millionNot Optionable

Recent News About These Companies

Versus Systems Inc.
Versus Systems Inc
Why Versus Systems (VS) Is 'One to Watch'
Versus System Inc
IBN Initiates Coverage of Versus Systems Inc.
Versus Systems collaborate with Drinkfinger

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Amesite stock logo

Amesite NASDAQ:AMST

$1.12 -0.04 (-3.45%)
Closing price 04:00 PM Eastern
Extended Trading
$1.14 +0.01 (+1.34%)
As of 05:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Amesite Inc., an artificial intelligence driven platform and course designer, that provides online products in the United States. The company uses machine learning to offer a mass customized experience to learners. It serves businesses, universities and colleges, K-12 schools, museums, and non-profit organizations. Amesite Inc. was incorporated in 2017 and is headquartered in Detroit, Michigan.

Entero Therapeutics stock logo

Entero Therapeutics NASDAQ:ENTO

$3.65 +0.08 (+2.27%)
As of 08/24/2026

Entero Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of targeted and orally delivered therapies for the treatment of patients with gastrointestinal diseases. The company's pipeline candidates include latiglutenase, a targeted oral biotherapeutic for celiac disease designed to breakdown gluten into non-immunogenic peptides, currently under Phase 2 studies; and capeserod, a selective 5-HT4 receptor partial agonist under Phase 1 studies for the treatment of gastroparesis. It is also involved in the development of adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients, currently under Phase 2 studies for the treatment of exocrine pancreatic insufficiency in patients with cystic fibrosis and chronic pancreatitis; and niclosamide, an oral small molecule with anti-inflammatory inhibitor therapy, currently under Phase 2 studies for the treatment of ulcerative proctitis and ulcerative proctosigmoiditis, as well as immune checkpoint inhibitor-associated colitis and diarrhea in metastatic cancer patients. The company was formerly known as First Wave BioPharma, Inc. and changed its name to Entero Therapeutics, Inc. in May 2024. Entero Therapeutics, Inc. was incorporated in 2014 and is based in Boca Raton, Florida.

LM Funding America stock logo

LM Funding America NASDAQ:PWCM

$1.17 -0.15 (-11.36%)
As of 04:00 PM Eastern

LM Funding America, Inc. operates as a cryptocurrency mining and specialty finance company. It operates through two segments, Specialty Finance and Mining Operations. The company also engages in Bitcoin mining operations; and provides funding to nonprofit community associations. The company was founded in 2008 and is based in Tampa, Florida.

Versus Systems stock logo

Versus Systems NASDAQ:VS

$1.32 +0.03 (+1.92%)
Closing price 03:59 PM Eastern
Extended Trading
$1.32 0.00 (0.00%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Versus Systems Inc. develops and operates a business-to-business software platform in the United States and Canada. The company offers eXtreme Engagement Online platform that is designed primarily for in-venue main-board work in stadiums and arenas; Filter Fan Cam (FFC) platform, an augmented reality filtering tool that can be used for mobile and in-venue applications; and Winfinite, which allows brands, media companies, and advertising agencies to reach out to customers directly on their mobile devices. It also offers business-to-business software platform that allows video game publishers, developers, and other interactive media content creators in-game prizing and rewards based on the completion of in-content challenges. In addition, the company provides XEO technology platform that offers online audience engagement. It primarily sells its access to platform and service offerings through its direct sales organization. Versus Systems Inc. is headquartered in Vancouver, Canada.